GHSI - Guardion Health Sciences, Inc. Stock Price and Quote

GHSI [NASD]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	-	EPS (ttm)	-35.72	Insider Own	1.34%	Shs Outstand	1.23M	Perf Week	13.47%
Market Cap	8.19M	Forward P/E	-	EPS next Y	-6.50	Insider Trans	-	Shs Float	0.95M	Perf Month	4.19%
Income	-20.50M	PEG	-	EPS next Q	-1.50	Inst Own	7.70%	Short Float / Ratio	12.30% / 4.93	Perf Quarter	-8.67%
Sales	11.00M	P/S	0.74	EPS this Y	-73.70%	Inst Trans	-	Short Interest	0.12M	Perf Half Y	0.73%
Book/sh	21.51	P/B	0.35	EPS next Y	13.30%	ROA	-72.60%	Target Price	35.00	Perf Year	-70.56%
Cash/sh	11.94	P/C	0.63	EPS next 5Y	-	ROE	-77.00%	52W Range	5.80 - 31.50	Perf YTD	4.48%
Dividend	-	P/FCF	-	EPS past 5Y	10.30%	ROI	-111.00%	52W High	-75.94%	Beta	0.86
Dividend %	-	Quick Ratio	9.10	Sales past 5Y	119.80%	Gross Margin	42.40%	52W Low	30.69%	ATR	0.65
Employees	13	Current Ratio	10.30	Sales Q/Q	-12.90%	Oper. Margin	-	RSI (14)	53.30	Volatility	7.74% 9.69%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	77.70%	Profit Margin	-	Rel Volume	1.71	Prev Close	6.62
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	23.59K	Price	7.58
Recom	2.00	SMA20	6.38%	SMA50	-0.99%	SMA200	-4.60%	Volume	40,230	Change	14.50%

Jan-24-23 04:05PM	Guardion Health Sciences, Inc. Regains Compliance With Nasdaq Continued Listing Requirements GlobeNewswire
Jan-12-23 06:50AM	Daily Vickers Top Buyers & Sellers for 01/12/2023 Argus Research +10.10%
Jan-06-23 04:15PM	Guardion Health Sciences, Inc. Announces 1-for-50 Reverse Stock Split Effective on Pre-Market Opening on January 9, 2023 GlobeNewswire -15.97%
Nov-29-22 05:06PM	Guardion Health Sciences Announces Pricing of Aggregate $4.75 Million Institutional Private Placement of Series C and Series D Redeemable Preferred Stock GlobeNewswire
Nov-14-22 08:25AM	Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2022 GlobeNewswire -8.76%
08:00AM	Loading…
Oct-06-22 08:00AM	Guardion Health Sciences Announces Clinical Results Indicating that Viactiv® Omega Boost Gel Bites Increase Omega-3 Levels in Just 4 weeks GlobeNewswire +31.01%
Aug-11-22 08:20AM	Guardion Health Sciences Announces Financial Results for the Quarter Ended June 30, 2022 GlobeNewswire +12.53%
Jun-09-22 09:00AM	ISS Recommends Guardion Stockholders Vote for the Increase in Shares for Equity Plan and for the Reverse Stock Split at Guardions Upcoming 2022 Annual Stockholders Meeting GlobeNewswire -5.23%
Jun-01-22 08:38AM	Guardion Health Sciences Announces Agreement with OmegaQuant Laboratories GlobeNewswire
May-26-22 09:00AM	Guardion Health Sciences Announces New Viactiv Omega Boost Gel Bites Now Available for Purchase on Amazon GlobeNewswire +37.00%
May-12-22 08:13AM	Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2022 GlobeNewswire
May-03-22 03:45PM	Guardion Health Sciences to Present at the Planet MicroCap Showcase 2022 GlobeNewswire
Apr-27-22 09:00AM	Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV ACCESSWIRE +6.12%
Apr-11-22 09:17AM	Guardion Health Sciences Announces New Viactiv® Omega Boost Gel Bites Now Available for Purchase Via Viactiv® Shopify Store GlobeNewswire
Apr-01-22 09:03AM	Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2021 GlobeNewswire -7.51%
08:00AM	Loading…
Mar-11-22 08:00AM	Guardion Health Sciences to Participate in Fireside Chat at the 34th Annual Roth Conference GlobeNewswire
Feb-23-22 04:15PM	Guardion Health Sciences, Inc. Announces Closing of $11 Million Public Offering GlobeNewswire -7.68%
Feb-18-22 09:00AM	Guardion Health Sciences, Inc. Announces Pricing of $11 Million Public Offering GlobeNewswire -45.73%
Feb-17-22 09:00AM	Guardion Health Sciences, Inc. Announces Proposed Public Offering GlobeNewswire -34.12%
Feb-14-22 08:00AM	Guardion Health Sciences Launches New Viactiv® Omega BOOST Passion Fruit Flavored Gel Bites GlobeNewswire
Jan-24-22 08:30AM	Guardion Health Sciences Launches New Online Store for Viactiv GlobeNewswire
Jan-06-22 08:00AM	Guardion Health Sciences to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference GlobeNewswire
Dec-23-21 04:05PM	Guardion Health Sciences to Wind Down VectorVision Business Operations and Focus on Exploiting VectorVision Intellectual Property GlobeNewswire
Dec-16-21 08:00AM	Guardion Health Sciences Issues Letter to Shareholders GlobeNewswire
Dec-09-21 08:30AM	Guardion Health Sciences Appoints Experienced Healthcare Executive Michaela Griggs to its Board of Directors GlobeNewswire
Dec-03-21 08:00AM	Guardion Health Sciences to Present at the Benzinga Global Small Cap Conference GlobeNewswire -8.34%
Nov-10-21 08:37AM	Guardion Health Sciences Announces Financial Results for the Three Months Ended September 30, 2021 GlobeNewswire -5.11%
Oct-25-21 08:00AM	Guardion Health Sciences to Present at the Benzinga Global Small Cap Conference GlobeNewswire
Oct-14-21 08:00AM	Guardion Health Sciences Announces Corporate Milestones Designed to Strengthen Financial Results and Improve Customer and Investor Engagement GlobeNewswire
Oct-12-21 10:30AM	Guardion Health Sciences Stockholders Urged to Vote Their Shares for October 22, 2021 Annual Meeting GlobeNewswire
08:00AM	Loading…
Oct-05-21 08:00AM	Guardion Health Sciences to Present at the LD Micro Main Event Conference GlobeNewswire
Sep-27-21 09:15AM	Guardion Health Sciences to Present at the Benzinga Healthcare Small Cap Conference GlobeNewswire
Sep-09-21 08:30AM	Guardion Health Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference GlobeNewswire
Aug-16-21 08:15AM	Guardion Health Sciences Announces Financial Results for the Three Months Ended June 30, 2021, including $1,000,000+ of Sales from Viactiv® Products in the First Month of Guardions Ownership GlobeNewswire
Jul-22-21 04:15PM	Guardion Health Sciences to Exhibit at the American Society of Cataract and Refractive Surgery Annual Meeting GlobeNewswire
Jun-14-21 08:05AM	Guardion Health Sciences to Be Added to the Russell 3000 Index GlobeNewswire
Jun-03-21 08:17AM	Guardion Health Sciences Announces Appointment of Craig J. Sheehan as Chief Commercial Officer GlobeNewswire
Jun-02-21 09:07AM	Guardion Health Sciences Broadens Clinical Nutrition Product Offerings by Closing Acquisition of Activ Nutritional, which owns the Science Backed, Revenue-Generating Viactiv® Product Line, from Adare Pharmaceuticals GlobeNewswire
08:03AM	Guardion Health Sciences to Present at the LD Micro Virtual Invitational Conference on June 9, 2021 GlobeNewswire
May-18-21 09:25AM	Guardion Health Sciences to Acquire Activ Nutritional, LLC and Its Well-Known Viactiv® Brand of Products from Adare Pharmaceuticals, Inc. GlobeNewswire +12.10%
May-17-21 04:05PM	Guardion Health Sciences Announces Financial Results for the Three Months Ended March 31, 2021 GlobeNewswire
May-03-21 08:10AM	Guardion Health Sciences Initiates Placebo-Controlled Clinical Trial Involving Proprietary GlaucoCetin® Product GlobeNewswire
Mar-26-21 08:00AM	Guardion Health Sciences Announces Financial Results for the Three Months and Year Ended December 31, 2020 GlobeNewswire
Mar-16-21 08:00AM	Guardion Health Sciences Regains Compliance with Nasdaq Minimum Bid Price Rule GlobeNewswire
Mar-11-21 08:00AM	Guardion Health Sciences to Participate in Maxim Groups Inaugural Emerging Growth Virtual Conference GlobeNewswire +15.14%
Feb-26-21 08:57AM	Guardion Health stock tumbles after reverse stock split announcement MarketWatch -27.36%
08:00AM	Guardion Health Sciences Announces 1-for-6 Reverse Stock Split Effective Pre-Market Opening on Monday, March 1, 2021 GlobeNewswire
Jan-28-21 04:15PM	Malaysias Ho Wah Genting Berhad Advises Guardion Health Sciences That It Has received Regulatory Product Registration Approval for Second Immune Support Dietary Supplement Designed and Produced by Guardion Health Sciences GlobeNewswire +16.48%
Jan-27-21 08:30AM	Nasdaq Grants Guardion Health Sciences an Extension to March 15, 2021 to Regain Compliance with the $1.00 Minimum Bid Price Rule GlobeNewswire
Jan-07-21 01:46AM	Should Guardion Health Sciences (NASDAQ:GHSI) Be Disappointed With Their 94% Profit? Simply Wall St. +6.19%
Dec-28-20 04:20PM	Guardion Health Sciences Appoints Seasoned Nutritional Products Industry Leader Bret Scholtes as President and Chief Executive Officer GlobeNewswire -8.36%
Dec-16-20 08:00AM	Guardion Health Sciences Announces Development of New Vision/Energy Support Drink EPIQ-V GlobeNewswire
Nov-12-20 04:05PM	Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2020 GlobeNewswire -6.72%
Oct-28-20 08:30AM	Guardion Health Sciences Announces Newly-Published Data Demonstrating Superior Visual Function and Macular Carotenoid Changes Using Guardions Proprietary Lumega-Z® Formulation Compared to AREDS-2 Formulation GlobeNewswire
Oct-27-20 08:30AM	Guardion Provides Answers to Frequently Asked Questions Regarding the Reasons for Approving the Reverse Stock Split Proposal at Upcoming 2020 Annual Stockholders Meeting GlobeNewswire -16.72%
Oct-26-20 08:00AM	Guardion Health Sciences Announces Investigator-Initiated Clinical Trial of Lumega-Z GlobeNewswire +10.40%
Oct-05-20 09:15AM	We Think Guardion Health Sciences (NASDAQ:GHSI) Needs To Drive Business Growth Carefully Simply Wall St.
08:30AM	Guardion Provides Update on Strategy, Business Plans and Initiatives GlobeNewswire
Sep-11-20 05:20PM	Guardion Announces Virtual Annual Meeting of Stockholders GlobeNewswire -8.09%
Aug-27-20 08:30AM	Guardion Health Sciences Product Licensee Receives Registration Approval in Malaysia for Immune Support Supplement GlobeNewswire
Aug-12-20 04:05PM	Guardion Health Sciences Reports Results of Operations for Quarter Ended June 30, 2020 GlobeNewswire
Aug-06-20 04:05PM	Guardion Health Sciences to Report Second Quarter 2020 Financial Results on August 12, 2020 GlobeNewswire
Jul-21-20 08:30AM	Guardion Health Sciences Adds Experienced Vice President and Chief Financial Officer to Executive Management Team GlobeNewswire
Jul-15-20 09:00AM	Guardion Subsidiary VectorVision Receives Approval from Korean Intellectual Property Office for CSV-2000 Trademark GlobeNewswire
Jul-08-20 08:45AM	Guardion Health Sciences Announces Submission of Patent Application for Treatment of Certain Underlying Conditions Related to Eye Disease GlobeNewswire
Jun-30-20 05:00AM	Guardion Health Sciences Completes Delivery of $875,000 Order to Malaysian Corporate Customer GlobeNewswire
Jun-15-20 04:20PM	Guardion Health Sciences Names Dr. David Evans as Interim President and Interim Chief Executive Officer GlobeNewswire +12.93%
May-14-20 07:00AM	Guardion Health Sciences Reports First Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire -6.83%
May-12-20 07:05AM	Lumega-Z® Demonstrates Superiority in a Head-to-Head Study Showing Better Bioavailability of Carotenoids and Restoring Macular Pigment Density GlobeNewswire
Apr-15-20 09:05AM	Guardion Health Sciences to Present at the April 2020 Virtual Investor Summit GlobeNewswire -11.16%
Apr-14-20 11:00AM	Guardion Health Sciences Announces Launch of acuMMUNE: An Immuno-Supportive/Anti-Oxidant Complex GlobeNewswire
Apr-01-20 07:00AM	Guardion Health Sciences Receives Initial Order from Malaysian Company for Exclusive Immuno-Supportive Formula GlobeNewswire -6.62%
Mar-30-20 09:00AM	Guardion Health Sciences Reports 2019 Year End Results and Provides Corporate Update and Overview GlobeNewswire -7.09%
Mar-19-20 12:05PM	Guardion Health Sciences Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule GlobeNewswire
Mar-06-20 08:05AM	Guardion Health Sciences Receives $3.5 Million from Exercise of Warrants GlobeNewswire
Feb-26-20 07:00AM	Guardion Health Sciences Selected by Malaysian Listed Company to Develop an Immuno-Supportive Formula GlobeNewswire
Feb-06-20 07:00AM	Guardion® Announces Development of Unique Immuno-Supportive Complex Targeting Upper Respiratory Tract Infections GlobeNewswire +13.93%
Jan-07-20 11:02AM	Guardion® Appoints Experienced Executive to Lead Development and Expansion of Recently-Acquired NutriGuard Business Line GlobeNewswire -8.11%
Nov-14-19 07:00AM	Guardion Health Sciences, Inc. Reports Results for the Three and Nine Months Ended September 30, 2019 GlobeNewswire -8.52%
Oct-30-19 12:33PM	Guardion Health Sciences Closes $8.4 Million Underwritten Public Offering GlobeNewswire
Oct-28-19 09:21AM	Guardion Health Sciences Announces Pricing of $8.4 Million Underwritten Public Offering GlobeNewswire -34.80%
Oct-23-19 07:00AM	Guardion® Receives approval from USPTO for expanded claims for its Proprietary Medical Device, the MAPCAT SF GlobeNewswire
Oct-17-19 10:40AM	Here's Why We're A Bit Worried About Guardion Health Sciences's (NASDAQ:GHSI) Cash Burn Situation Simply Wall St.
Oct-10-19 10:30AM	Guardion® Announces Statistically Significant Blood Assay Study Results GlobeNewswire +5.10%
Sep-23-19 10:30AM	Guardion Health Sciences Acquires the NutriGuard Brand of Products GlobeNewswire +20.13%
Sep-03-19 02:08PM	Best & worst performing IPOs in 2019 Yahoo Finance Video
07:00AM	Guardion Launches VectorVision CSV-2000 Standardized Contrast Sensitivity Test GlobeNewswire
Aug-15-19 04:05PM	Guardion Health Sciences Closes $5.8 Million Underwritten Public Offering GlobeNewswire
08:35AM	Guardion Health Sciences Announces an Increase in the Pricing of its Previously Announced Underwritten Public Offering GlobeNewswire
Aug-13-19 09:00AM	Guardion Health Sciences Announces Pricing of $5.2 Million Underwritten Public Offering GlobeNewswire -59.66%
Aug-12-19 08:40AM	Guardion Health Sciences Reports June 30, 2019 Interim Results of Operations GlobeNewswire -8.49%
Aug-06-19 07:00AM	Foundation Fighting Blindness selects Guardions VectorVision CSV-1000 Diagnostic Instrument for Use in Large-Scale Multi-Center Clinical Trial GlobeNewswire
Jul-19-19 02:47PM	What Type Of Shareholder Owns Guardion Health Sciences, Inc.'s (NASDAQ:GHSI)? Simply Wall St.
Jul-17-19 07:00AM	Guardions Proprietary Medical Device, the MapcatSF®, Receives Patent from the Hong Kong Patents Registry GlobeNewswire +93.75%
Jun-20-19 07:00AM	Guardions Proprietary Medical Device, the MapcatSF®, Receives Patent from the European Union GlobeNewswire +7.23%
Jun-04-19 07:00AM	Guardion Launches Second Ocular Health Formula GlaucoCetin GlobeNewswire +24.84%
May-09-19 10:14AM	Guardions Lumega-Z Formula Associated with Substantial Clinical Improvement in Patients Contrast Sensitivity Visual Function (CSF) vs AREDS 2 GlobeNewswire
May-07-19 07:00AM	Guardion's Lumega-Z Formula Associated with Improved Vision in Patients with Severe Glaucoma GlobeNewswire
May-01-19 07:00AM	Guardion Health Sciences, Inc. Receives Official Trademark Registrations in China GlobeNewswire +6.36%
Apr-17-19 09:01AM	Results of Lumega-Z Data to be Presented at ARVO GlobeNewswire -12.00%

Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatSF, a medical device that measures the macular pigment optical density; CSV-1000 device that offers auto-calibrated tests to ensure the correct testing luminance and contrast levels; and CSV-2000, a digital standardized contrast sensitivity testing device, as well as develops, manufactures, and sells equipment and supplies for standardized vision testing under the VectorVision name for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. In addition, the company develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Radoff Bradley Louis	10% Owner	Jan 10	Buy	7.60	31,900	242,353	217,900	Jan 11 05:11 PM
Radoff Bradley Louis	10% Owner	Jan 09	Buy	6.88	84,821	583,487	186,000	Jan 11 05:11 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience